港股異動丨李寧(2331.HK)漲逾3% 股價創歷史新高
格隆匯8月17日丨李寧(2331.HK)漲逾3%,報32.55港元創歷史新高,今年以來漲幅近40%,總市值805.4億港元。李寧上週五發布公告,截至2020年6月30日止六個月,按比較基準(扣除上年同期一次性與經營無關的損益),權益持有人應占淨溢利上升約22%至6.83億元人民幣。匯豐研究隨後將李寧目標價由29.6港元上調至36.4港元,評級維持“買入”。美銀證券稱,來自李寧的品牌高利潤、成本控制,及其他效率改善一同強化,重申“買入”評級,目標價升12%至36港元,以反映更高的估值預期。大和則將李寧目標價由28.5港元上調至34港元,評級由“買入”降至“跑贏大市”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.